Group 1 - The State Financial Supervision Administration and seven other departments issued measures to support financing for small and micro enterprises, emphasizing the establishment of a coordination mechanism for financing support [1] - The measures include conducting extensive visits to small and micro enterprises to assess their operational status and financing needs, facilitating direct access to bank credit [1] - There is a focus on addressing the operational difficulties faced by small and micro enterprises and encouraging support for key sectors such as foreign trade, private enterprises, technology, and consumption [1] Group 2 - In May 2025, a total of 130 domestic online games were approved by the National Press and Publication Administration [2] Group 3 - The State Council announced the removal of Wang Jianjun from the position of Vice Chairman of the China Securities Regulatory Commission [3] Group 4 - The Shanghai Municipal Government issued a plan to boost consumption, which includes measures to promote reasonable income growth and improve wage distribution mechanisms [4] - The plan aims to enhance the minimum wage adjustment mechanism and support the development of the rural economy and new business models [4] Group 5 - Shanghai is accelerating the introduction of childcare subsidies and maternity social security subsidies as part of its efforts to build a family-friendly society [5] - The city plans to explore increasing parental leave and spouse's paternity leave while enhancing the quality of public kindergartens [5] Group 6 - The Ministry of Foreign Affairs stated that China has the capability and confidence to handle external risks, including tariff wars, as evidenced by a 2.4% year-on-year increase in total goods import and export in the first four months of the year [6] - Exports grew by 7.5%, indicating strong international competitiveness despite high tariff barriers [6] Group 7 - The Ministry of Foreign Affairs expressed strong opposition to the EU's unilateral sanctions against Chinese companies, emphasizing the need for fair trade practices [8] - The ministry highlighted that normal business interactions between Chinese and Russian companies should not be disrupted by these sanctions [8] Group 8 - The Dalian Commodity Exchange announced trading arrangements for the Dragon Boat Festival period, with a market closure from May 31 to June 2, 2025, and a return to normal trading on June 3 [9] Group 9 - Heng Rui Pharmaceutical set the issuance price for its H-shares at HKD 44.05 per share [11] - Xinyuan Technology plans to issue H-shares and list on the Hong Kong Stock Exchange [11] - The company Guokai Microelectronics is planning a major asset restructuring, leading to a suspension of its stock from May 22 [11]

Key Points - Vanke A has signed a supplementary agreement with Shenzhen Metro Group for a loan of up to 4.2 billion yuan, with a pledge of up to 6 billion yuan in shares of its subsidiary, Wanwu Cloud [3] - Heng Rui Pharmaceutical has set the final price for its H-share issuance at 44.05 HKD per share, with plans to list on the Hong Kong Stock Exchange on May 23, 2025 [4] - Wan Dong Medical has elected Ma Chibing as the new chairman after Hu Ziqiang resigned from the position [5] - Tianqi Mould has confirmed that there are no undisclosed significant matters amid ongoing major asset restructuring [6] - Zhejiang Rongtai plans to invest 20 million yuan to establish a wholly-owned subsidiary focused on intelligent robotics [7] - ST Mingcheng intends to publicly transfer 45% of its subsidiary, Time Media, which will no longer be included in the consolidated financial statements [8] - Shanghai Xiba plans to purchase patent assets for 2 million yuan and 500,000 yuan, and establish subsidiaries to promote the commercialization of new technologies [9] - Jushen Co. has received a total of 95.7 million yuan in dividends from its six wholly-owned subsidiaries [10] - ST Asia Pacific has confirmed no undisclosed significant matters or ongoing major plans [11] - Tianrong Tianyu's controlling shareholder's agreement will not be renewed after its expiration [12] - Wangzi New Materials has stated that its energy storage capacitor business is minimal and will not significantly impact its performance [13] - Nanjing Port has clarified that its foreign trade container business does not have direct routes to the U.S. [14] - Jinlongyu has indicated that its solid-state battery business has not yet formed stable long-term revenue [15] - Tianzhihang's subsidiary plans to raise capital by introducing investors [16] - State Grid Information plans to acquire 100% of Yili Technology for 1.853 billion yuan, enhancing its revenue and profit [17] - ST Nongsang will remove its delisting risk warning starting May 23 [18] - Yipin Hong has stated that its innovative drug AR882 has not yet been launched and will not significantly impact recent performance [19] - Huanrui Century has announced a performance compensation plan requiring original shareholders to compensate 116 million shares [20] - Huaren Health plans to acquire stakes in three pharmaceutical chain companies for a total of 3.282 billion yuan [21][22] - Hongming Co. is planning to acquire 83% of Shenzhen Chisu for 1.51 billion yuan [23] - Aishida intends to acquire an additional 7% stake in its subsidiary Qianjiang Robot for 13.09 million yuan [24] - Dasheng Intelligent has signed a contract worth 11.5 million yuan for a high-efficiency machine room project [25] - Jinggu Co. has received a notice to supply wheels for a major global automaker, with expected sales of approximately 158 million USD over ten years [26] - Pingzhi Information has signed a framework agreement with China Mobile for antenna products worth up to 13.01 million yuan [27] - Shanghai Laishi's controlling shareholder plans to increase its stake by 250 million to 500 million yuan [28] - Qixia Construction's shareholder plans to reduce its stake by up to 3% [29] - Sichuan Gold's major shareholders plan to reduce their stakes by up to 5.5% [30] - Qingyun Technology's shareholders plan to reduce their stakes by up to 4.5% [31] - Rhein Biological's directors plan to reduce their stakes by up to 0.14% [32] - Qingmu Technology's shareholder plans to reduce its stake by up to 3% [33] - Sanrenxing's employee shareholding platform plans to reduce its stake by up to 3% [34][35] - Juzhi Technology's director plans to reduce his stake by up to 40,000 shares [36] - Jingwang Electronics' major shareholders plan to reduce their stakes by up to 2.99% [37] - Jujiao Co. plans to reduce its stake by up to 2.6% [38] - Xiyu Tourism's major shareholder plans to reduce its stake by up to 3% [39]

Group 1 - Huiyu Pharmaceutical's subsidiary received drug registration certificate for Carboxymethyl Sodium Injection, which is used for treating bleeding diseases in various medical fields [1] - Baihe Co., Ltd. announced a plan for a director to reduce holdings by up to 424,000 shares, representing 0.6625% of the total share capital [1] - Kingood Co., Ltd. received a notification from a global leading automaker for a wheel project, expected to start mass production in 2026 with a lifecycle of 10 years [1][2] Group 2 - Wanhua Chemical plans to repurchase shares worth between 300 million and 500 million yuan, with a maximum repurchase price of 99.36 yuan per share [2] - Warner Pharmaceutical's subsidiary received approval for Acetylcysteine raw material drug, primarily used for treating respiratory diseases [3] - ST Mingcheng plans to publicly transfer 45% equity of its subsidiary, aiming to optimize asset structure [4] Group 3 - Qixia Construction announced a plan to reduce up to 31.5 million shares, accounting for 3% of total share capital [5][6] - Zhejiang Rongtai intends to invest 20 million yuan to establish a wholly-owned subsidiary focused on intelligent robotics [7] - Yuandong Biological received drug registration for Chloral Hydrate Enema, used for sedation and seizure control in children [9] Group 4 - Jiemai Technology's subsidiary signed a strategic cooperation agreement with a solid-state battery company to produce high-safety composite conductive materials [10] - Xianju Pharmaceutical received drug registration for Progesterone Soft Capsules, used for treating functional disorders due to luteal deficiency [11] - Lanhua Kecai's subsidiary reported a temporary production halt, with the resumption date yet to be determined [13] Group 5 - Sinopharm Modern's subsidiary received drug registration for Tocilizumab Tablets, used for treating rheumatoid arthritis and other conditions [15] - Shanghai Bank announced the resignation of its vice president due to organizational adjustments [17] - Shanghai Pharmaceutical's Ephedrine Injection passed the consistency evaluation for generic drugs [19] Group 6 - Rundu Co., Ltd. received drug registration for Amlodipine and Olmesartan Tablets, aimed at treating hypertension [21] - Zhong'an Technology announced that 61 million shares held by its controlling shareholder will be auctioned [23] - Shanghai Washba plans to purchase patent assets and establish two subsidiaries focused on hydrogen energy and solid-state battery technologies [25] Group 7 - Nuo Cheng Jianhua's new drug Tafasitamab received approval for treating relapsed/refractory diffuse large B-cell lymphoma [26] - Benli Technology plans to use up to 200 million yuan of idle funds for cash management and financial investments [28] - Taiji Co., Ltd. intends to use 60 million yuan of idle funds to purchase financial products [29] Group 8 - Haishi Co. announced that its innovative drug Anreke Fen Injection received drug registration for treating postoperative pain [32] - Yulong Co. will have its stock delisted on May 27, 2025, following a decision by the Shanghai Stock Exchange [36] - Weifu High-Tech plans to establish a joint venture with Shanghai Baolong Automotive Technology [38] Group 9 - Xichang Electric Power expects a net profit reduction of approximately 5.4 million yuan due to adjustments in the time-of-use electricity pricing mechanism [39] - Alter signed a contract worth 6.8 billion yen for the development and procurement of large truck EV kits [41] - Zhonglian Heavy Industry plans to acquire controlling stakes in its financing leasing subsidiary through public bidding [42] Group 10 - Sanyou Medical's executive plans to reduce holdings by up to 1.44% of the company's shares [43] - Hangyang Co. plans to establish a subsidiary for large modular cryogenic equipment manufacturing with an estimated investment of 557 million yuan [44] - FAW Fuwi received a notification for a dashboard project from a well-known new energy brand, with total sales expected to reach 1.06 billion yuan [45]

本资产评估报告依据中国资产评估准则编制 武汉当代明诚文化体育集团股份有限公司拟股权转让 所涉及的武汉当代时光传媒有限公司 股东全部权益价值评估项目 资产评估报告 湖北玖誉[2025]资评报字第 043 号 (全一册) 湖北到 百有限公司 户六日 中国资产评估协会 资产评估业务报告备案回执 | 报告编码: | 4242160001202500052 | | --- | --- | | 合同编号: | DDMC-T2-202504-007 | | 报告类型: | 法定评估业务资产评估报告 | | 报告文号: | 湖北玖誉[2025]资评报字第043号 | | 报告名称: | 武汉 当代明诚文化体育集团股份有限公司拟股权转让所涉及的武 | | | 汉当代时光传媒有限公司股东全部权益价值评估项目 | | 评估结论: | 6,058,004.66元 | | 评估报告日: | 2025年05月06日 | | 评估机构名称: | 湖北玖誉房地产评估有限公司 | | 签名人员: | 彭雨 薇 (资产评估师) 正式会员 编号: 42200036 | | | 朱元杰 (资产评估师) 正式会员 编号:42190071 | (可扫描 ...

武汉当代明诚文化体育集团股份有限公司 关于关联租赁的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券代码：600136 证券简称：ST明诚 公告编号：临2025-026号 武汉当代明诚文化体育集团股份有限公司（以下简称"公司"）全资子公 司湖北联影创艺文化传媒有限公司（以下简称"联影创艺"）拟租赁湖北清能酒 店管理集团有限公司（以下简称"清能酒管"）旗下湖北清江饭店用于营业性演 出。 清能酒管为公司关联方，本次交易构成关联交易。 本次交易不构成重大资产重组。 本次关联交易总金额约为562.25万元，未超过公司最近一期经审计净资产 的5%，因此无需提交股东大会审议。 一、关联交易基本情况 （一）关联交易简介 为加快公司全资子公司联影创艺的业务开展速度，强化其可持续发展能力， 联影创艺拟租赁清能酒管旗下湖北清江饭店用于营业性演出，租赁期六年，租赁 建筑面积2,590平方米，租金合计约为562.25万元。 （二）关联交易履行的审议程序 1、独立董事专门会议审议情况 2025年5月21日，公司召开了独立董事专 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 武汉当代明诚文化体育集团股份有限公司（以下简称"公司"）拟通过公 开挂牌转让的方式出售控股子公司武汉当代时光传媒有限公司（以下简称"时光 传媒"）45%股权。交易完成后，时光传媒将不再纳入公司合并报表范围。 本次出售资产事项不构成重大资产重组。 本次出售资产事项尚需履行公开挂牌转让程序，交易能否达成存在不确定 性。 一、交易概述 证券代码：600136 证券简称：ST明诚 公告编号：临2025-025号 武汉当代明诚文化体育集团股份有限公司 关于以公开挂牌转让的方式出售资产的公告 为优化资产结构，推动可持续发展,公司于2025年5月21日召开第十届董事会 第二十二次会议，审议通过了《关于以公开挂牌转让的方式出售资产的议案》， 同意公司以公开挂牌转让的方式出售时光传媒45%股权。 公司聘请了湖北玖誉房地产评估有限公司对时光传媒进行了评估，评估基准 日为2024年12月31日。经评估，时光传媒股东全部权益价值为605.80万元，较净 资产账面值-3.74万元，增值60 ...

证券代码：600136 证券简称：ST 明诚 公告编号：临 2025-024 号 武汉当代明诚文化体育集团股份有限公司 关于变更公司全称并修订《公司章程》的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 1、变更前公司中文全称：武汉当代明诚文化体育集团股份有限公司 变更后公司中文全称：武汉明诚文化体育集团股份有限公司 2、变更前公司英文全称：WUHAN DDMC CULTURE & SPORTS CO.,LTD. 变更后公司英文全称：WUHAN MC CULTURE & SPORTS CO.,LTD. 3、变更前公司英文简称：DDMC （二）公司变更全称的原因 在完成低效资产的重整剥离以及债务结构的优化调整后,公司立足于原文化 产业基础，开启了业务拓展与转型升级的进程，成功构建了"文化+运营"双轮 驱动体系，以支持经营发展战略。随着业务规模和覆盖范围的持续扩大，为进一 步契合未来发展方向，提升产品与服务质量，推动公司稳健高效发展，增强品牌 形象及客户信任，公司决定对全称进行变更。 综上所述，本次变更公司全 ...

证券代码：600136 证券简称：ST 明诚 公告编号：临 2025-027 号 武汉当代明诚文化体育集团股份有限公司 关于召开2024年年度股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一) 股东大会类型和届次 2024年年度股东大会 股东大会召开日期：2025年6月19日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 (二) 股东大会召集人：董事会 (三) 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结 合的方式 (四) 现场会议召开的日期、时间和地点 召开的日期时间：2025 年 6 月 19 日 10 点 00 分 召开地点：公司会议室 (五) 网络投票的系统、起止日期和投票时间。 (六) 融资融券、转融通、约定购回业务账户和沪股通投资者的投票程序 涉及融资融券、转融通业务、约定购回业务相关账户以及沪股通投资者的投 票，应按照《上海证券交易所上市公司自律监管指引第 1 号—规范运作》等有关 规定执行。 二、 会议审议事 ...

一、监事会会议召开情况 （一）本次监事会会议的召开符合有关法律、行政法规、部门规章、规范性 文件和公司章程的规定。 （二）本次监事会会议通知和会议资料于 2025 年 5 月 16 日以通讯方式发出。 （三）本次监事会会议于 2025 年 5 月 21 日以通讯方式召开。 （四）本次监事会会议应出席监事 3 人，实际出席会议监事 3 人。 二、监事会会议审议情况 证券代码：600136 证券简称：ST明诚 公告编号：临2025-023号 （一）关于关联租赁的议案 武汉当代明诚文化体育集团股份有限公司 第十届监事会第十九次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 监事会审议通过上述议案并认为： 《关于关联租赁的议案》已获公司全体独立董事同意。为审议本次关联租赁 事项，公司召开了第十届董事会第二十二次会议，关联董事回避了该事项的表决， 会议的召开符合相关法律法规及《公司章程》的规定。本次关联租赁定价公允， 交易条件符合公平原则，不存在损害公司和股东利益的情形，交易结果不会对公 司的经营造成重大影响。 特此公告。 ...

证券代码：600136 证券简称：ST 明诚 公告编号：临 2025-022 号 武汉当代明诚文化体育集团股份有限公司 第十届董事会第二十二次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 （一）本次董事会会议的召开符合有关法律、行政法规、部门规章、规范性文 件和公司章程的规定。 （二）本次董事会会议通知和会议资料于 2025 年 5 月 16 日以通讯方式发出。 （三）本次董事会会议于 2025 年 5 月 21 日以通讯方式召开。 （四）本次董事会会议应出席董事 9 人，实际出席会议董事 9 人。 二、董事会会议审议情况 1 （一）关于变更公司全称并修订《公司章程》的议案 本议案表决结果为：9 票赞成，0 票反对，0 票弃权。本议案获得通过。本议案 尚需提交股东大会审议。 公司关于变更公司全称并修订《公司章程》的公告将同日刊登于《中国证券报》 《上海证券报》《证券时报》《证券日报》和上海证券交易所网站（www.sse.com.cn）。 （二）关于以公开挂牌转让的方式出售资产的议案 本议 ...